Role of Mitochondrial Markers in Improved Detection and Risk-Stratification in Barrett’s Esophagus Patients

Barrett’s esophagus (BE) is the only known precursor of esophageal adenocarcinoma (EAC) and is amenable to treatment. However, more than 90 percent of EAC patients are never diagnosed with antecedent BE. Identification of molecular markers for BE is needed to improve detection of BE through efficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Grewal, Udhayvir S., Randhawa, Mehraj S., Mehta, Aryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: YJBM 2019
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747936/
https://www.ncbi.nlm.nih.gov/pubmed/31543714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747936/
https://www.ncbi.nlm.nih.gov/pubmed/31543714

Ejemplares similares